Viewing Study NCT03942068


Ignite Creation Date: 2025-12-24 @ 5:44 PM
Ignite Modification Date: 2026-03-02 @ 4:11 AM
Study NCT ID: NCT03942068
Status: UNKNOWN
Last Update Posted: 2019-05-08
First Post: 2019-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer
Sponsor: Henan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module